Topics

Pharmaceuticals

CVS to hire 15,000 workers ahead of flu season, COVID-19 vaccines

CVS to hire 15,000 workers ahead of flu season, COVID-19 vaccines

Source: Reuters
Date of Publication: October 19th, 2020
U.S. pharmacy chain CVS Health Corp on Monday said it will hire 15,000 employees in the fourth quarter of this year as the onset of winter could fuel a resurgence in the spread of COVID-19 and flu cases.
AmerisourceBergen_Chronically Simple App Enhanced to Meet the COVID-19 Challenges of the Medically Vulnerable_AmerisourceBergen

Chronically Simple App Enhanced to Meet the COVID-19 Challenges of the Medically Vulnerable

By: AmerisourceBergen
Source: AmerisourceBergen
Date of Publication: April 17th, 2020
New features, including fever, symptom and medication tracking, are now available for free to first-time users to support high-risk populations navigating COVID-19
The AmerisourceBergen Foundation Commits Global Support to Aid Communities, Individuals and Associates Impacted by COVID-19

The AmerisourceBergen Foundation Commits Global Support to Aid Communities, Individuals and Associates Impacted by COVID-19

By: AmerisourceBergen
Source: AmerisourceBergen
Date of Publication: March 27th, 2020
Grants provided to diverse organizations help to address vulnerable populations, mental health needs, economic challenges and changing circumstances for existing nonprofit partners
Bob Mauch_COVID-19 Letter_AmerisourceBergen

A letter from Bob Mauch

By: Bob Mauch
Source: AmerisourceBergen
Date of Publication: March 30th, 2020
A letter from AmerisourceBergen CEO Bob Mauch to employees and customers regarding the company's response.
Gates Foundation enlists Novaris, GSK, others in Covid19 fight

Gates Foundation enlists Novaris, GSK, others in Covid19 fight

By: Jenni Spinner
Source: Outsourcing-Pharma.com
Date of Publication: March 27th, 2020
The global collaboration brings together several pharmaceutical giants to accelerate the development and delivery of coronavirus tests and therapies.
LegoChem Biosciences, Iksuda collaborate to develop antibody-drug conjugates - Pharmaceutical Business review

LegoChem Biosciences, Iksuda collaborate to develop antibody-drug conjugates

By: PBR staff writer
Source: Pharmaceutical Business Review
Date of Publication: April 17th, 2020
LegoChem Biosciences, based in Daejeon, South Korea, announced today that it has entered a research collaboration and license agreement with Iksuda Therapeutics (“Iksuda”) for the development of antibody-drug conjugates in oncology.
Coronavirus Vaccine_ Two Pharma Giants Collaborating To Develop One _ Coronavirus Live Updates _ NPR

Coronavirus Vaccine? Two Pharmaceutical Giants Collaborating To Develop One

By: Joe Palca
Source: NPR
Date of Publication: April 14th, 2020
Two of the world's largest vaccine manufacturers, GlaxoSmithKlein and Sanofi, are joining forces to develop a new vaccine to prevent COVID-19.
Pharma giants including Novartis collaborate on COVID-19 therapies

Pharma Giants Including Novartis

By: Richard Staines
Source: PharmaPhorum
Date of Publication: March 26th, 2020
A consortium of life sciences companies including pharma giants such as Novartis and Johnson & Johnson, will collaborate to develop and manufacture vaccines, diagnostics and treatments for COVID-19 in a response to the coronavirus pandemic.